Amprius Technologies (NYSE:AMPX) Research Coverage Started at Needham & Company LLC

Needham & Company LLC initiated coverage on shares of Amprius Technologies (NYSE:AMPX) in a research note published on Thursday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $20.00 target price on the stock.

AMPX has been the topic of a number of other reports. Northland Securities set a $20.00 price target on shares of Amprius Technologies in a research note on Tuesday, October 7th. Oppenheimer reiterated an “outperform” rating and issued a $17.00 target price on shares of Amprius Technologies in a report on Tuesday, December 23rd. Roth Mkm set a $14.00 target price on Amprius Technologies and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Weiss Ratings restated a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Finally, Cantor Fitzgerald raised their price target on Amprius Technologies from $12.00 to $16.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Seven equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $16.57.

Amprius Technologies Price Performance

Shares of AMPX stock opened at $12.42 on Thursday. The company has a market capitalization of $1.62 billion, a PE ratio of -47.77 and a beta of 3.04. The firm’s 50-day moving average is $10.27 and its two-hundred day moving average is $10.04. Amprius Technologies has a 12 month low of $1.70 and a 12 month high of $16.03.

Amprius Technologies (NYSE:AMPX) last announced its quarterly earnings results on Thursday, November 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.03. The business had revenue of $21.43 million during the quarter, compared to the consensus estimate of $16.45 million. Amprius Technologies had a negative net margin of 53.16% and a negative return on equity of 38.85%. Sell-side analysts forecast that Amprius Technologies will post -0.45 EPS for the current year.

Insider Activity

In related news, CTO Constantin Ionel Stefan sold 492,827 shares of the firm’s stock in a transaction that occurred on Thursday, January 22nd. The shares were sold at an average price of $12.04, for a total value of $5,933,637.08. Following the sale, the chief technology officer directly owned 748,696 shares of the company’s stock, valued at approximately $9,014,299.84. This trade represents a 39.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kang Sun sold 1,000,000 shares of the company’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $10.60, for a total transaction of $10,600,000.00. Following the transaction, the chief executive officer directly owned 1,472,306 shares of the company’s stock, valued at $15,606,443.60. This trade represents a 40.45% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,399,331 shares of company stock worth $37,048,615 over the last quarter. 12.90% of the stock is currently owned by company insiders.

Institutional Trading of Amprius Technologies

Institutional investors have recently made changes to their positions in the stock. Quarry LP acquired a new position in Amprius Technologies in the third quarter valued at $42,000. Jones Financial Companies Lllp increased its stake in Amprius Technologies by 353.2% during the third quarter. Jones Financial Companies Lllp now owns 4,532 shares of the company’s stock worth $50,000 after acquiring an additional 3,532 shares during the last quarter. Parallel Advisors LLC purchased a new position in shares of Amprius Technologies in the 3rd quarter worth about $54,000. Geneos Wealth Management Inc. acquired a new position in shares of Amprius Technologies in the 3rd quarter valued at about $74,000. Finally, Ameritas Investment Partners Inc. grew its holdings in shares of Amprius Technologies by 2,043.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock worth $40,000 after purchasing an additional 9,072 shares during the period. 5.04% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Needham initiated coverage with a Buy and a $20 price target (roughly +61% upside from current levels), a bullish analyst catalyst that likely drew buyer interest and helped fuel recent gains. Needham initiates coverage of Amprius
• Positive Sentiment: MarketBeat highlighted Amprius’ expanding production capacity and new South Korean manufacturing partners, noting the company is ahead of plan and positioning for an improved path to profitability ahead of FY2025 Q4 results (late March) — a concrete operational improvement that supports longer‑term upside. 5 Stocks to Buy in February: Last Year’s Winners Aren’t Done Yet (AMPX)
• Positive Sentiment: Unusual options activity: a large purchase of call options (22,391 contracts) suggests elevated bullish/speculative interest and short‑term upside betting by traders — this can amplify intraday moves and volatility.
• Neutral Sentiment: Several outlets ran takeaways asking whether recent multi‑month gains make AMPX “too late” to buy and examining valuation after a big run; these pieces increase retail attention but don’t settle fundamentals one way or the other. Is It Too Late To Consider Buying Amprius Technologies (AMPX)
• Negative Sentiment: Zacks noted a recent sharp intraday gain but flagged that the trend in earnings‑estimate revisions does not support sustained upside — a warning that analysts’ expectations may not be accelerating enough to justify the rally. Amprius (AMPX) Moves 13.4% Higher: Will This Strength Last?
• Negative Sentiment: Fundamental risk: Amprius still shows negative net margin and negative ROE and trades with a high beta — meaning the stock is sensitive to sentiment swings and could face profit‑taking or re‑rating if upcoming earnings fail to show clear progress toward profitability.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.